Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction

BackgroundThe objective of the study was to identify any changes in primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in England by analysing procedural numbers, clinical characteristics and patient outcomes during the COVID-19 pandemic.MethodsWe conduct...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Heart (British Cardiac Society) Ročník 106; číslo 23; s. 1805 - 1811
Hlavní autori: Kwok, Chun Shing, Gale, Chris P, Kinnaird, Tim, Curzen, Nick, Ludman, Peter, Kontopantelis, Evan, Wu, Jianhua, Denwood, Tom, Fazal, Nadeem, Deanfield, John, de Belder, Mark A, Mamas, Mamas
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England BMJ Publishing Group Ltd and British Cardiovascular Society 01.12.2020
BMJ Publishing Group LTD
Predmet:
acute myocardial infarction
Aged
Angioplasty
Betacoronavirus
Clinical outcomes
Communicable Disease Control
Coronary artery disease
Coronavirus Infections - epidemiology
Coronaviruses
COVID-19
Demographics
England
Ethnicity
Female
Health care access
Heart attacks
Hospital Mortality
Humans
Male
Middle Aged
Mortality
Pandemics
Patients
percutaneous coronary intervention
Percutaneous Coronary Intervention - statistics & numerical data
Pneumonia, Viral - epidemiology
Procedures and Techniques Utilization
Retrospective Studies
SARS-CoV-2
Society
ST Elevation Myocardial Infarction - diagnosis
ST Elevation Myocardial Infarction - mortality
ST Elevation Myocardial Infarction - therapy
Time-to-Treatment
Treatment Outcome
England
United Kingdom > UK
percutaneous coronary intervention
acute myocardial infarction
ISSN:1355-6037, 1468-201X, 1468-201X
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:BackgroundThe objective of the study was to identify any changes in primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in England by analysing procedural numbers, clinical characteristics and patient outcomes during the COVID-19 pandemic.MethodsWe conducted a retrospective cohort study of patients who underwent PCI in England between January 2017 and April 2020 in the British Cardiovascular Intervention Society-National Institute of Cardiovascular Outcomes Research database. Analysis was restricted to 44 hospitals that reported contemporaneous activity on PCI. Only patients with primary PCI for STEMI were included in the analysis.ResultsA total of 34 127 patients with STEMI (primary PCI 33 938, facilitated PCI 108, rescue PCI 81) were included in the study. There was a decline in the number of procedures by 43% (n=497) in April 2020 compared with the average monthly procedures between 2017 and 2019 (n=865). For all patients, the median time from symptom to hospital showed increased after the lockdown (150 (99–270) vs 135 (89–250) min, p=0.004) and a longer door-to-balloon time after the lockdown (48 (21–112) vs 37 (16–94) min, p<0.001). The in-hospital mortality rate was 4.8% before the lockdown and 3.5% after the lockdown (p=0.12). Following adjustment for baseline characteristics, no differences were observed for in-hospital death (OR 0.87, 95% CI 0.45 to 1.68, p=0.67) and major adverse cardiovascular events (OR 0.71, 95% CI 0.39 to 1.32, p=0.28).ConclusionsFollowing the lockdown in England, we observed a decline in primary PCI procedures for STEMI and increases in overall symptom-to-hospital and door-to-balloon time for patients with STEMI. Restructuring health services during COVID-19 has not adversely influenced in-hospital outcomes.
Bibliografia:Original research
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1355-6037
1468-201X
1468-201X
DOI:10.1136/heartjnl-2020-317650